Page last updated: 2024-10-28

hexamethonium and Neuralgia

hexamethonium has been researched along with Neuralgia in 3 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Neuralgia: Intense or aching pain that occurs along the course or distribution of a peripheral or cranial nerve.

Research Excerpts

ExcerptRelevanceReference
"Myocardial infarction is the leading cause of death worldwide."1.46Cardioprotection induced in a mouse model of neuropathic pain via anterior nucleus of paraventricular thalamus. ( Chang, YT; Chen, CC; Chen, WH; Chen, YH; Cheng, YF; Shih, HC; Shyu, BC, 2017)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, YF1
Chang, YT1
Chen, WH1
Shih, HC1
Chen, YH1
Shyu, BC1
Chen, CC1
FOWLER, FD1
MOSER, M1
ROSE, JC1
WEMPLE, JN1

Other Studies

3 other studies available for hexamethonium and Neuralgia

ArticleYear
Cardioprotection induced in a mouse model of neuropathic pain via anterior nucleus of paraventricular thalamus.
    Nature communications, 2017, 10-10, Volume: 8, Issue:1

    Topics: Animals; Butadienes; Chronic Pain; Disease Models, Animal; Enzyme Inhibitors; Ganglionic Blockers; H

2017
Use of hexamethonium and dibenzyline in diagnosis and treatment of causalgia.
    Journal of the American Medical Association, 1956, Jul-14, Volume: 161, Issue:11

    Topics: Cardiovascular Agents; Causalgia; Hexamethonium; Muscle Relaxants, Central; Neuralgia; Phenoxybenzam

1956
Hexamethonium (C6) in the management of causalgia.
    United States Armed Forces medical journal, 1951, Volume: 2, Issue:6

    Topics: Bis-Trimethylammonium Compounds; Causalgia; Disease Management; Hexamethonium; Neuralgia

1951